Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trial

Autor: Wilop, S., Tometten, M., Korfel, A., Keller, U., de Wit, M., Weissinger, F., Stark, U., Behringer, D., Bückner, U., Nückel, H., Schroers, R., Trenn, G., Hertenstein, B., Bernhard, H., Heike, M., Wörns, M.-A., Kroschinsky, F., Prange-Krex, G., Giagounidis, A., Grigoleit, G. U., Selbach, J., Petrasch, S., Balleisen, J. S., Schütte, J., Dienst, A., Germing, U., Dührsen, U., von Verschuer, U., Reimer, P., Höffkes, H.-G., Runde, V., Spohn, C., Moeller, R., Dürk, H., Kofahl-Krause, D., Heuser, M., Witzens-Harig, M., Müller-Tidow, C., Martens, U. M., Strumberg, D., La Rosée, P., Hochhaus, A., Link, H., Held, G., Kneba, M., Baldus, C., Naumann, R., Chemnitz, J. M., Schulte, K., Limmroth, C., Schwarzer, A., Niederwieser, D., Platzbecker, U., Heil, G., Schwalenberg, M., Grieshammer, M., Beck, C., Stephany, M., Mesters, R., Karsten, I. E., Held, H., Mahlmann, S., Steiniger, H., Gaska, T., Südhoff, T., Kreisel-Büstgens, C., Moorahrend, E., Maschmeyer, G., Jordan, K., Kloke, O., Klein, M., Höhler, T., Grube, M., Herr, W., Hahn, D., Raghavachar, A., Schmalz, O., Fett, W., Sandmann, M., Krohn, T., Brenner, W., Plotkin, M., Franzius, C., Kotzerke, J., Hautzel, H., Bockisch, A., Hertel, A., Bengel, F. M., Haberkorn, U., Freesmeyer, M., Lützen, U., Klein, A., Kluge, R., Larisch, R., Fricke, E., Holzinger, J., Schäfer, W., Weckesser, M., Nyuyki, F., Römer, W., Brink, I., Marienhagen, J., Pöpperl, G., Jöckel, K.-H., Nonnemacher, M., Rekowski, J., Scherag, A., Neuhäuser, M., Dührsen, Ulrich, Bockisch, Andreas, Hertenstein, Bernd, Karsten, Imke E., Kroschinsky, Frank, Heuser, Michael, Hochhaus, Andreas, Höffkes, Heinz-Gert, Behringer, Dirk, Prange-Krex, Gabriele, Tometten, Mareike, Grieshammer, Martin, Grigoleit, Götz U., Schmalz, Oliver, Jordan, Karin, Bernhard, Helga, Gaska, Tobias, Giagounidis, Aristoteles, Schroers, Roland, Martens, Uwe M., Held, Gerhard, Klapper, Wolfram, Jöckel, Karl-Heinz, Nonnemacher, Michael, Hüttmann, Andreas

Publikováno v: In Blood Neoplasia September 2024 1(3)

1348P First-line (1L) nivolumab (N) + ipilimumab (I) with 2 cycles of platinum-based chemotherapy (C) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC): Results from an interim analysis of the German non-interventional study (NIS) FINN

Autor: Kuon, J.B., Von der Heyde, E., Sadjadian, P., Bischoff, M., Hassler, A., Althoff, A., Wilop, S., Behringer, D.M., Blau, W., Hübner, G., Flieger, D., Ziske, C., Groschek, M., Laack, H-E., Mueller-Huesmann, H., Schumann, C., Waldenberger, D., Gütz, S.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S852-S852

Comparison of flow-FISH and MM-qPCR telomere length assessment techniques for the screening of telomeropathies

Autor: Ferreira, M.S.V., Kirschner, M., Halfmeyer, I., Estrada, Natalia, Xicoy, Blanca, Isfort, S., Vieri, M., Zamora, Lurdes, Abels, A., Bouillon, A.S., Begemann, M., Schemionek, M., Maurer, A., Koschmieder, S., Wilop, S., Panse, J., Brümmendorf, T.H., Beier, F., Universitat Autònoma de Barcelona

Publikováno v: Recercat. Dipósit de la Recerca de Catalunya
instname
Annals of the New York Academy of Sciences 1466(1), 93-103 (2020). doi:10.1111/nyas.14248 special issue: "Special Issue: Hematopoietic Stem Cells X"
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)

Assessment of telomere length (TL) in peripheral blood leukocytes is part of the diagnostic algorithm applied to patients with acquired bone marrow failure syndromes (BMFSs) and dyskeratosis congenita (DKC). Monochrome multiplex-quantitative polymera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbc41e22b1393fc84af5fd513d215823
http://hdl.handle.net/2072/444861

First-line nivolumab (NIVO) plus ipilmumab (IPI) with two cycles of chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC): Results from an interim analysis of the non-interventional FINN study. (German)

Autor: Kuon, J, von der Heyde, E, Bischoff, M, Wilop, S, Behringer, D, Blau, W, Hübner, G, Flieger, D, Forstbauer, H, Groschek, M, Laack, H, Müller-Huesmann, H, Schumann, C, Waldenberger, D, Gütz, S

Publikováno v: Pneumologie; 2024 Supplement 1, Vol. 78, pS102-S103, 2p

Identification of patients with classical and/or cryptic dyskeratosis congenita (DKC) by telomere length screening using different percentiles : results from the Aachen telomeropathy registry

Autor: Beier, F., Kirschner, M., Bouillon, A-S, Halfmeyer, I., Ferreira, Ventura M., Kricheldorf, K., Maurer, A., Wilop, S., Thol, F., Roeth, A., Platzbecker, U., Radsak, M., Ayuk, F. A., Corbacioglu, S., Hoechsmann, B., Wilk, C. M., Hinze, C., Chromik, J., Egle, A., Bittenbring, J. T., Eggermann, T., Kurth, I., Koschmieder, S., Mirle Schemionek, Isfort, S., Panse, J., Bruemmendorf, T. H.

Publikováno v: Web of Science

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::09f1dcb48920ddc9666d3f16f43fe643